Publications by authors named "Daniela Ehrsam-Tosi"
Adaptive servo-ventilation (ASV) effectively treats sleep-disordered breathing, including central sleep apnea (CSA) and coexisting obstructive sleep apnea (OSA). The prospective, multicenter European READ-ASV (Registry on the Treatment of Central and Complex Sleep-Disordered Breathing with Adaptive Servo-Ventilation) registry investigated the effects of first-time ASV therapy on disease-specific quality of life (QoL). The registry enrolled adults with CSA with or without OSA who had ASV therapy prescribed between September 2017 and March 2021.
View Article and Find Full Text PDFArticle Synopsis
- Adaptative servo-ventilation (ASV) is effective in treating central sleep apnea but its real-world usage and effects on quality of life are not well understood.
- This study followed 801 patients prescribed ASV from 2017 to 2021, analyzing their symptoms, quality of life (QoL), and reasons for ASV therapy.
- Common reasons for ASV usage included persistent CSA and CSA associated with cardiovascular disease, with many patients showing severe symptoms and low quality of life scores at baseline. One-year follow-up data will help assess the impact of ASV on their QoL and overall health outcomes.*